1. Therapeutic targeting of CK2 in acute and chronic leukemias
   F Buontempo et al, 2017, Leukemia CrossRef
2. Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
   Camilla Evangelisti et al, 2018, IJMS CrossRef
3. MNK1 inhibitor CGP57380 overcomes mTOR inhibitor-induced activation of eIF4E: the mechanism of synergic killing of human T-ALL cells
   Xian-bo Huang et al, 2018, Acta Pharmacol Sin CrossRef
4. Overexpression of CD59 inhibits apoptosis of T-acute lymphoblastic leukemia via AKT/Notch1 signaling pathway
   Yanfei Jia et al, 2019, Cancer Cell Int CrossRef
5. Novel targeted therapeutic agents for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma
   Matthew J. Barth et al, 2019, Br J Haematol CrossRef
6. Autophagy in acute leukemias: A double-edged sword with important therapeutic implications
   Cecilia Evangelisti et al, 2015, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
7. Differential profile of PIP4K2A expression in hematological malignancies
   Keli Lima et al, 2015, Blood Cells, Molecules, and Diseases CrossRef
8. How I treat T-cell acute lymphoblastic leukemia in adults
   Mark R. Litzow et al, 2015 CrossRef
9. Targeting Wnt/β‐catenin and PI3K/Akt/mTOR pathways in T‐cell acute lymphoblastic leukemia
   Cecilia Evangelisti et al, 2020, J Cell Physiol CrossRef
10. miR-125b regulates differentiation and metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20
    Zixing Liu et al, 2016, Oncotarget CrossRef
11. Recent Advances in Molecular Diagnosis and Prognosis of Childhood B Cell Lineage Acute Lymphoblastic Leukemia (B-ALL)
    Manisha Agarwal et al, 2020, Indian J Hematol Blood Transfus CrossRef
12. Comparison of rapamycin and methylprednisolone for treating inflammatory muscle disease in a murine model of experimental autoimmune myositis
    Juan Kang et al, 2020, Exp Ther Med CrossRef
13. SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome
    Saara Laukkanen et al, 2020, Leukemia & Lymphoma CrossRef
14. PTEN/PI3K/Akt pathway alters sensitivity of T-cell acute lymphoblastic leukemia to l-asparaginase
    Katerina Hlozkova et al, 2022, Sci Rep CrossRef
15. Anlotinib exerts an anti-T-cell acute lymphoblastic leukemia effect in vitro and in vivo
    Xingming Zhang et al, 2023, Cellular Signalling CrossRef